| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies. | Blood | 2013 | 1.56 |
| 2 | Antibody-maytansinoid conjugates designed to bypass multidrug resistance. | Cancer Res | 2010 | 1.11 |
| 3 | Disulfide-linked antibody-maytansinoid conjugates: optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkage. | Bioconjug Chem | 2011 | 1.01 |